Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Physical Chemistry Letters|September 22, 2025
Anion Engineering of Ionic Liquid-Based Polymer Electrolytes for Interfacial Stabilization in Lithium Metal BatteriesRunhong Wei, Li Niu, Yanlei Zhang, et al.
Nanotechnology|November 6, 2020
Biological enzyme treatment of starch-based lithium-ion battery silicon-carbon compositeRunhong Wei, Ruhui Xu, Keyu Zhang, et al.
The Journal of Chemical Physics|May 15, 2026
Dynamics and charge transport in PVDF-HFP/protic ionic liquid (PIL) membranes: The effect of PIL concentrationRunhong Wei, Li Niu, Jessica Mangialetto, et al.
Soft Matter|August 22, 2023
The cohesive properties and pyrolysis mechanism of an aprotic ionic liquid tetrabutylammonium bis(trifluoromethanesulfonyl)imideShijie Liu, Runhong Wei, Guangjun Ma, et al.
Cancer Immunology, Immunotherapy : CII|May 18, 2021
Lenalidomide enhances the efficacy of anti-BCMA CAR-T treatment in relapsed/refractory multiple myeloma: a case report and revies of the literatureGuoxing Zhao, Runhong Wei, Lei Feng, et al.
Cancer Gene Therapy|December 15, 2023
An alternative fully human anti-BCMA CAR-T shows response for relapsed or refractory multiple myeloma with anti-BCMA CAR-T exposures previouslyQingming Wang, Runhong Wei, Shufang Guo, et al.
The Journal of Chemical Physics|November 22, 2024
Enhanced decoupling of conductivity relaxation from structural relaxation in non-stoichiometric protic ionic liquids involving triflic acid and 2-aminoethyl hydrogen sulfateJinhai You, Jessica Mangialetto, Bing-Yu Li, et al.
Nano-Micro Letters|July 29, 2024
Boosting High-Voltage Practical Lithium Metal Batteries with Tailored AdditivesJinhai You, Qiong Wang, Runhong Wei, et al.
Clinical and Experimental Medicine|July 28, 2025
A bi-specific CAR-T cell therapy targeting CD19 and CD22 in relapsed or refractory B-ALLQiuling Ma, Runhong Wei, Qingming Wang, et al.
American Journal of Hematology|April 30, 2022
CAR-T cell therapy targeting B cell maturation antigen is effective for relapsed/refractory multiple myeloma, including cases with poor performance statusJuan Du, Runhong Wei, Songfu Jiang, et al.
Pageof 2